检索

The efficacy offixed combination of bisoprolol and amlodipine in patients with arterial hypertension, ischemic heart disease and metabolic syndrome

Skibickiy V., Fendrikova A., Skibickiy A., Syrotenko D.

(Rus)

The hardness of the vessel wall in patients with arterial hypertension

Ostroumova O., Kochetkov A., Kopchenov I., Guseva T., Bondarec O.

(Rus)

卷 11, 编号 4 (2014)

Arterial hypertension and brain damage. New targets of therapy

Yanishevskiy S., Mirnaya D., Andreyev R.

(Rus)

Pleiotropic features of dihydropyridine calcium channel antagonists

Anikin G.

(Rus)

Pharmacoepidemiological study of recommendations of diuretics for the treatment of hypertension in the outpatient setting

Ponomareva A., Kompaniets O., Linchak R., Nemirovskaya M., Strokan M., Babich A.

(Rus)

The problem of determining the efficiency of treatmentin the era of evidence-based medicine: international and domestic experience

Gilyarevsky S.

(Rus)

The results of the open observational, international, multicenter, prospective program to assess the efficacy, safety and tolerability of the first direct renin inhibitor RasilezR (aliskiren) in patients with arterial hypertension in ‘real-life’ clinical practice settings (DRIve)

Chazova I.

(Rus)

National questionnaire of treatment compliance:testing and application in outpatient practice

Fofanova T., Ageev F., Smirnova M., Svirida O., Kuzmina A., Thostov A., Nelyubina A.

(Rus)

Aldosterone synthase gene polymorphism in patients with hypertension combined ischemic heart disease with in various left ventricular mass

Yahontov D., Derisheva D., Gulyaeva L.

(Rus)

卷 10, 编号 4 (2013)

Modern possibilities of hypertension drug therapy. Candesartan and its place in the therapy

Barbarash O., Kashtalap V.

Efficacy of irbesartan in arterial hypertension and metabolic syndrome

Ostroumova O., Zykova A., Polosova T., Bondarets O.

卷 10, 编号 1 (2013)

Effect of the fixed-dose combination Ekvator on blood pressure level and cognitive functions in elderly patients with arterial hypertension

Ostroumova O., Pervichko E.

Electrical and viscoelastic parameters of erythrocytes in patients with different degrees of arterial hypertension

Gromov A., Kruchinina M., Rabko A., Baum V., Generalov V.

B-ADRENOBLOCKERS IN THERAPY FOR ARTERIAL HYPERTENSION: ON THE WAY TO REASONABLE COMPROMISE

Perepech N., Shurygina V.

卷 6, 编号 2 (2009)

Perindopril in treatment of patients with arterial hypertension and high cardiovascular risk

Недогода С., Nedogoda S.

卷 18, 编号 2 (2021)

Consensus of experts from the Russian Medical Society of Arterial Hypertension. Arterial hypertension and erectile dysfunction

Alekseeva T., Litvin A., Elfimova E., Mikhailova O., Larina V., Shpot E., Podzolkov V., Chazova I.

(Rus)

Implementation of the organoprotective properties of fixed combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with grade 2 and 3 hypertension in the Russian clinical study VICTORY II

Obesity as a risk factor of contrast-induced acute kidney injury in patients with arterial hypertension and stable coronary artery disease

Mironova O., Sivakova O., Fomin V.

(Rus)

卷 17, 编号 3 (2020)

Chazova I., Martynyuk T., Rodnenkov O., Gorieva S., Rogoza A., Arkhipov M., Grinshtein Y., Ostroumova O., Galiavich A., Rotar’ O., Khaisheva L., Kameneva T.

(Rus)

卷 17, 编号 2 (2020)

Clinical guidelines on arterial hypertension diagnosis, treatment and prevention in children and adolescents

Aleksandrov A., Kisliak O., Leontyeva I.

(Rus)

Heart rate variability in women with essential hypertension under exposure of regular moderate physical training

Smolyakov Y., Kuznik B., Guseva E., Davydov S.

(Rus)

Fleita is a Russian randomized, open-label, multicenter, comparative program for the evaluation of the efficacy and safety of the fixed combination drug Tarka (ABBOTT Laboratories, USA) versus optional sustained-release antihypertensive drugs in the treatment of patients with arterial hypertension and cognitive disorders (stepwise strategy)

Role of fixed combinations in modern treatment of arterial hypertension: new or well overlooked old?

Adasheva T., Samorukova E., Zadionchenko V., Laricheva K.

(Rus)

卷 16, 编号 3 (2019)

Target levels of blood pressure in the elderly and very old patients with chronic kidney disease without frailty

Ostroumova O., Cherniaeva M.

(Rus)

卷 6, 编号 4 (2009)

Chazova I., Ostroumova O.

Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients withtype 2 diabetes mellitus and mild hypertension:a sequential, randomized, double-blind clinical trial

Giuseppe Derosa -., Arrigo FG Cicero -., Angela D'Angelo -., Elena Fogari -., Sibilla Salvadeo -., Alessia Gravina -., Ilaria Ferrari -., Raffaella Fassi -., Roberto Fogari -.

Arterial hypertension and treatment of non steroidal anti-inflammatory drugs: advantage amlodipin

Ezhov M., Yezhov M.

Communication of subcutaneous, visceral, periaortic, epicardial fat and metabolic parameters with arterial stiffness in young people with abdominal obesity

Zheleznova E., Zhernakova Y., Chazova I., Rogoza A., Zairova A., Shariya M., Yarovaya E., Orlovsky A., Blinova N., Azimova M., Gorieva S., Konosova I.

(Rus)

Advantages of control over the course of hypertension disease with the fixed combination of amlodipine and perindoprilе arginin

Alyokhina O., Chesnokova I.

(Rus)

卷 15, 编号 1 (2018)

Organoprotective properties of therapy by fixed combination of perindoprile and amlodipine in patients with arterial hypertension and diabetes mellitus type 2

Statsenko M., Turkina S., Titarenko M.

(Rus)

卷 14, 编号 3 (2017)

Interaction of antihypertensive drugs and rosuvastatin: focus on safety, efficiency and prospects

Luchinina E., Kompaniets O., Kizhvatova N.

(Rus)

卷 14, 编号 4 (2017)

Markers of early target-organ brain damage in essential arterial hypertension: the search continues. Possibilities of diffusion tensor magnetic resonance imaging

Parfenov V., Ostroumova T., Ostroumova O., Perepelova E., Perepelov V.

(Rus)

卷 14, 编号 2 (2017)

A new fixed combination of perindopril, indapamide and amlodipine. "Three in one" is the way to improve the results of arterial hypertension treatment

Temnikova E.

(Rus)

卷 14, 编号 1 (2017)

Angiotensin receptor blocker telmisartan: efficacy, safety and relevance of clinical application

Maksimov M., Dralova O.

(Rus)

卷 14, 编号 1 (2017)

Cardiovascular risk factors in people with high normal blood pressure in Russian population (based on data obtained in ESSE-RF epidemiological study)

Efremova Y., Oshchepkova E., Zhernakova Y., Chazova I., Iarovaia E., Shalnova S., Rotar O., Konradi A., Shliakhto E., Boitsov S.

(Rus)

卷 13, 编号 4 (2016)

A fixed combination of amlodipine and losartan: effectiveness and safety in abnormal weather conditions in patients with arterial hypertension

Ageev F., Smirnova M., Fofanova T., Blankova Z., Vitsenya M., Tsybulskaya T., Neverova E., Samsonova N.

(Rus)

卷 13, 编号 2 (2016)

Chronotherapy’s opportunities of a fixed combination of perindopril 10 mg/indapamide 2.5 mg in patients with a lack of night reduction in blood pressure

Aksenova A., Elfimova E., Litvin A., Chazova I.

(Rus)

卷 12, 编号 4 (2015)

Clinical effects of one-year physical training program in arterial hypertension patients of working age who have suffered acute myocardial infarction (Russian randomized controlled trial)

Aronov D., Bubnova M., Krasnitskiy V., Ioseliani D., Grinshteyn Y., Gulyaeva S., Efremushkin G., Lyamina N.

(Rus)

卷 12, 编号 4 (2015)

Torasemid in the treatment of cardiovascular disease: the optimal use in conditions of comorbidity

Poteshkina N., Troshina A.

(Rus)

Central and humoral mechanisms for arterial hypertension in women

Podzolkov V., Bragina A., Rodionova J., Koloda J.

(Rus)

卷 12, 编号 3 (2015)

Fixed dose combinations for the treatment arterial hypertension: the real way to improve control

Morozova T., Andreev S.

(Rus)

The role of beta-blockers in the treatment of arterial hypertension: what do we know today

Zhernakova Y., Chazova I.

(Rus)

Ser49Gly polymorphic markers associations of ADRB1 gene and 4a/4b eNOS gene with hypertension and ischemic heart disease among the population of mountain shoria natives

Mulerova T., Rubtsova E., Kuz'mina A., Tatarnikova N., Maksimov V., Voevoda M., Ogarkov M.

(Rus)

Autoregulation hemodynamics in pregnancies complicated by hypertensive disorders

Makarov R., Kinzhalova S., Davydova N.

(Rus)

卷 11, 编号 4 (2014)

Dispersible Prestarium A tablets in the treatment of patients with arterial hypertension

Malchikova S., Tarlovskaya Y.

(Rus)

The combination therapy in arterial hypertension: opportunities of the fixed combination of irbesartan andhydrochlorothiazide(Koaprovel’)

Ostroumova O., Guseva T., Bondarets O.

(Rus)

Angiotensin II receptor blockers in the treatment of arterial hypertension in patients with concomitant pathology: focus on candesartan

Trukhan D.

(Rus)

Recommendations on treatment strategies in hypertensivepatientswithmetabolic disorders

Zhernakova Y., Chazova I.

(Rus)

Place of arterial hypertension in brain lesion development - from minor cognitive disorders to dementia

Shishkova V.

(Rus)

The value of blood pressure variability in clinical practice. Opportunities of amlodipine in reducing blood pressure variability (based on the Russian program «VARIATIONS»)

Ostroumova O., Bondarets O., Guseva T.

(Rus)

卷 10, 编号 4 (2013)

Coagulogic risk factors of heart disease in the adult population of Tomsk

Dobrovolsky A., Titaeva E., Yarovaya E., Storozhilova A., Zhernakova Y., Oschepkova E., Panchenko E., Trubacheva I., Serebryakova V., Kaveshnikova V., Chazova I., Karpov R.

Additional possibilities of antihypertensive therapy for metabolic syndrome

Kislyak O., Pokhilchenko M.

Torasemide: additional benefits for postmenopausal women with arterial hypertension

Tkacheva O., Runikhina N., Sharashkina N.

卷 10, 编号 1 (2013)

Hypertension treatment: Is there a place for b-adrenoblockers?

Minushkina L.

Aspects of efficacy, safety and adherence to antihypertensive therapy with single pill combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with 2 and 3 grade of arterial hypertension in the Russian clinical study VICTORY II

The abilities of losartan in angioprotection in hypertensive patients with hyperuricemia

Nedogoda S., Ledyaeva A., Chumachok E., Tsoma V., Salasyuk A.

卷 6, 编号 2 (2009)

Amlodipin in the treatment of arterial hypertension

Galyavich A.

卷 18, 编号 3 (2021)

Efficacy and safety of azilsartan medoxomil in various doses in patients with metabolic disorders

Perepech N., Chazova I., Zhernakova J.

(Rus)

卷 18, 编号 1 (2021)

Chazova I., Martynyuk T., Rodnenkov O., Gorieva S., Rogoza A., Arkhipov M., Grinshtein Y., Ostroumova O., Galyavich A., Rotar’ O., Khaisheva L., Kameneva T.

(Rus)

The place of fixed antihypertensive drugs in modern therapy of arterial hypertension

Pinchuk T., Orlova N.

(Rus)

卷 17, 编号 3 (2020)

Parameters of acute vasoreactivity testing after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension

Yarovoy S., Chazova I., Matchin Y., Danilov N.

(Rus)

Gender-age peculiarities of smoking and diabetes mellitus role in the development of myocardial infarction in patients with arterial hypertension

Aksenova A., Oshchepkova E., Orlovsky A., Chazova I.

(Rus)

Target blood pressure levels in patients with arterial hypertension and frailty

Ostroumova O., Cherniaeva M., Morozov A.

(Rus)

卷 16, 编号 2 (2019)

Evaluation of compliance of pulmonary hypertension patients to the treatment with inhaled iloprost (Ventavis): results of prospective, multicenter, non-interventional IVENT study

Martynyuk T.

(Rus)

卷 6, 编号 3 (2009)

Performance of the Program of prevention and treatment of arterial hypertension in Ukraine (1999-2007)

Sirenko Y.

卷 6, 编号 4 (2009)

Diuretics in treatment of patients with arterial hypertension

Chazova I., Ratova L.

卷 6, 编号 3 (2009)

Whether all ACE inhibitors enzyme are identical? Focus on zofenopril.

Ratova L., Chazova I.

Evaluation of subclinical cardiotoxicity in patients with breast cancer and arterial hypertension in two regimens of anthracycline-containing chemotherapy

Avalyan A., Oshchepkova E., Saidova M., Shitov V., Glazkova E., Stenina M., Chazova I.

(Rus)

The role of b-blockers in the new revision of the 2018 European guidelines for the diagnosis and treatment of arterial hypertension in the patients with comorbidities

Ostroumova O., Kochetkov A.

(Rus)

卷 15, 编号 3 (2018)

Guidelines for diagnostics and treatment of hypertension 2018 - European experts’opinion [Guidelines]

Chazova I., Zhernakova Y.

(Rus)

卷 14, 编号 3 (2017)

The efficacy and safety of torasemid in the treatment of arterial hypertension in different clinical situations

Ostroumova O., Piksina G., Smolyarchuk E., Pavleeva E., Bondarets O.

(Rus)

卷 14, 编号 4 (2017)

Modern concepts of the relationship between obesity and erectile dysfunction in patients with arterial hypertension

Alekseeva T., Litvin A.

(Rus)

卷 14, 编号 2 (2017)

Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)

Marwick T., Gillebert T., Aurigemma G., Chirinos J., Derumeaux G., Galderisi M., Gottdiener J., Haluska B., Ofili E., Segers P., Senior R., Tapp R., Zamorano J., Khadzegova A., Matskeplishvili S., Krikunov P.

(Rus)

卷 13, 编号 4 (2016)

The choice of antihypertensive therapy in correction of cognitive impairments and prevention of dementia: possibilities of valsartan and fixed-dose combination of valsartan and hydrochlorothiazide

Ostroumova O., Garelik I., Karavashkina E.

(Rus)

卷 13, 编号 4 (2016)

Radiofrequency renal arteries denervation: effectively and safely

Grigin V., Danilov N., Matchin Y., Chazova I.

(Rus)

卷 13, 编号 2 (2016)

The major arteries and skin microcirculatory vessels status and antihypertensive therapy effect on them in hypertensive patients with high and very high cardiovascular risk

Mordvinova E., Oshchepkova E., Fedorovich A., Zairova A., Pogorelova O., Tripoten M., Rogoza A.

(Rus)

卷 13, 编号 1 (2016)

The role of b-blockers in treatment of hypertension, according to Russian and European experts

Ostroumova O., Fomina V., Shchukina G., Smoliarchuk E.

(Rus)

卷 12, 编号 3 (2015)

Radiofrequency denervation of renal arteries. Myth or reality?

Grigin V., Danilov N., Matchin Y., Chazova I.

(Rus)

Patients with arterial hypertension associated with metabolic disorders: characteristics and therapeutic approach

Zhernakova Y., Sharipova G., Chazova I.

(Rus)

The recommendations review concerning the maintenance of patients with arterial hypertension: evidence and expert opinions

Samorodskaya I., Boitsov S.

(Rus)

卷 11, 编号 4 (2014)

Once again about the clinical efficacy and safety of sartans

Minina Y., Khadzhieva B.

(Rus)

Perindopril is angiotensin-converting enzyme inhibitor in treatment patients with arterial hypertension

Martynov A., Urlaeva I., Akatova Y., Nikolin O.

(Rus)

The benefits of candesartan usage in the treatment of arterial hypertension

Ostroumova O., Bondarets O., Guseva T.

(Rus)

Experience of treating hypertension in an outpatient setting: a clinical case

Agafonov A., Khozyainova N., Petruschenkova O.

(Rus)

Study of the relationship social and psychological characteristics of hypertensive patients, the frequency of medical emergencies and adherence of patients to treatment

Chumakova E., Gaponova N.

(Rus)

Hypertension treatment features in perimenopausal women

Zhernakova Y., Chazova I.

(Rus)

卷 10, 编号 4 (2013)

Modern approaches to combined therapy of arterial hypertension

Napalkov D., Zhilenko A.

Use of diuretics in hypertensive patients with metabolic disturbances

Zhernakova Y., Chazova I.

卷 10, 编号 1 (2013)

Effect of adrenalectomy on the condition of the myocardium and arteries in hypertensive patient with primary hyperaldosteronism

Valieva Z., Chikhladze N., Sakhnova T., Blinova E., Panteleev I., Tripoten M., Balakhonova T., Chazova I.

Iloprost for acute tests in patients with pulmonary arterial hypertension

Belyatko E., Danilov N., Matchin Y., Martynyuk T., Chazova I.

Diuretics in arterial hypertension: a focus on torasemide

Baryshnikova G., Stepanova I.

卷 6, 编号 2 (2009)

Efficacy of metoprolol in treatment and preventive of cardiovascular diseases

Chazova I., Ratova L., Ratova L., Chazova I.

Contrast-associated acute kidney injury in patients with arterial hypertension and coronary artery disease and its long-term prognosis

Mironova O., Fomin V.

(Rus)

卷 17, 编号 3 (2020)

Contrast-associated acute kidney injury in patients with arterial hypertension and stable coronary artery disease

Mironova O., Fomin V.

(Rus)

Risk factors for falls in patients with arterial hypertension

Khovasova N., Naumov A., Tkacheva O., Moroz V.

(Rus)

卷 16, 编号 1 (2019)

Obesity and hypertension: the role of criteria

Tsygankova D., Krivoshapova K., Maksimov S., Indukaeva E., Shapovalova E., Artamonova G., Barbarash O.

(Rus)

卷 6, 编号 4 (2009)

Rationale for the use of sartans in patients with arterial hypertension

Stryuk R.

Metabolic syndrome

Mychka V., Chazova I., Mychka V., Chazova I.